Histological diagnosis according to WHO classification and determination of usual
prognostic factors are necessary to choose between treatment options in non-Hodgkin …

The clinical features, histopathological types, treatment modalities and response, and
survival analysis were evaluated in our 114 patients with non-Hodgkin lymphoma (NHL). At …

The Groupe d'Etude des Lymphomes de l'Adulte (GELA) has conducted several phase II
and III studies in patients with aggressive lymphoma, diffuse large B-cell lymphoma …

The Revised European-American Classification of Lymphoid Neoplasms was recently
developed to address the shortcomings of the National Cancer Institute Working Formulation …

Aggressive non-Hodgkin's lymphomas (NHL) in localized stages I and II, without bulky areas
and a fair International Prognostic Factor (IPI)(30% of all cases) have high possibilities of …

Non-Hodgkin's lymphoma (NHL) is not a single disease, but a group of closely related B-and
T-cell cancers of the lymphatic system. The incidence of NHL is rising, particularly in the …

The past decade has seen enormous changes in our understanding of lymphomas with a
better classification (World Heath Organization) and identification of better prognostic …

The present status of the following aspects of diagnosis and treatment of malignant
lymphoma are reviewed, and future directions are discussed. 1. Epidemiology 2 …

Once the diagnosis of a non-Hodgkin's lymphoma (NHL) has been established three critical
steps in patient management must follow. The first is the pre-treatment evaluation and …

The NHL represent a complex group of neoplastic diseases with variable natural history and
widely divergent patterns of response to treatment. Their classification still remains a highly …